ConductScience.org, home

Gene · 10406

Papers3,333

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.Cardiovasc Pathol202642242639PubTator, text miningPubMed
Integrative epidemiological and experimental evidence implicates CCNA2-associated macrophage-hepatocyte crosstalk in dimethyl phosphate exposure-associated NAFLD.Environ Pollut202642235667PubTator, text miningPubMed
Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.Cancer Epidemiol Biomarkers Prev202642233870PubTator, text miningPubMed
Smartphone-Operated FRET Platform with Aggregation-Induced Emission MOFs and Spiky Carbon Nanospheres for Rapid Quantification of CA125 and HE4.ACS Sens202642227770PubTator, text miningPubMed
Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.Eur J Clin Invest202642227653PubTator, text miningPubMed
Integrated multi-omics analysis: exploring the molecular regulatory mechanisms of HIV infection and identifying the key gene WFDC2.Clin Exp Med202642223712PubTator, text miningPubMed
Antibody-conjugated species-sorted single-walled carbon nanotubes for multiplexed cytokine sensing.Commun Mater202642221745PubTator, text miningPubMed
Rational Design of Optical Single-Walled Carbon Nanotube-Based Nanosensors with Biological Recognition Elements.Adv Sens Res202642220420PubTator, text miningPubMed
Predictive ability of novel glycovariant biomarkers of CA125 and CA15-3 up to three years prior to ovarian cancer diagnosis: a population-based case-control study.J Ovarian Res202642215983PubTator, text miningPubMed
Decoding the delirium proteome: linking clinical vulnerabilities to acute brain dysfunction.J Gerontol A Biol Sci Med Sci202642209428PubTator, text miningPubMed
Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study.Front Med (Lausanne)202642200085PubTator, text miningPubMed
Correspondence on "The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatment" by Morell et al.Int J Gynecol Cancer202642150974PubTator, text miningPubMed
Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.Hum Reprod Update202642143676PubTator, text miningPubMed
Determination of HE4 in pleural fluid and ratio: considerations and diagnostic performance for malignant pleural effusion.Adv Lab Med202642136980PubTator, text miningPubMed
Adding HE4 to the IOTA ADNEX model for differentiating adnexal masses: A Danish prospective, multicenter study.Gynecol Oncol202642134000PubTator, text miningPubMed
CA125 Outperforms HE4 and CA19-9 as a Serum Biomarker for Preoperative Diagnosis of Ovarian Endometriomas: A Retrospective Cohort Study.Reprod Sci202642115575PubTator, text miningPubMed
Clinically relevant histopathological features and biomarkers in endometrial cancer.Ceska Gynekol202642113616PubTator, text miningPubMed
Utility of pre-operative magnetic resonance imaging (pelvis and abdomen) and combined tumour markers HE4 and CA125 in diagnosing early and advanced carcinoma endometrium.Med J Armed Forces India202642111886PubTator, text miningPubMed
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritis.Clin Chim Acta202642107815PubTator, text miningPubMed
Enhanced Prediction of Peripheral Artery Disease Using Plasma Proteomics Among Individuals Without Diabetes.J Am Heart Assoc202642089180PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10406/papers?page=4